People, Startups, Venture

Pfizer spins off drug orphans into a PhIII-ready startup backed by Bain to the tune of $103M

Insiders

The top 5 trends in biotech - #3: High valuations for attractive biotechs are a durable symptom of a thriving financing arena

Biotech Voices, Workforce

Visualize: What would these 8 biotech companies look like without immigrants?
More news caret

calendar Protocols

Quick hits from around the biopharma web

Sep 25

Spark recruits gene therapy expert Mingozzi as new CSO; Fusion brings venture round to $46M; China OKs Gilead’s Sovaldi for hep C

Sep 22

AbbVie partners on an Opdivo combo study with Bristol-Myers; Intercept tumbles on FDA warning

Sep 20

Arcus scores $305M regional development pact with Taiho; Shire, Shionogi tout PhIII ADHD study

Sep 19

OptiNose files for $100M IPO; GSK wins three-in-one COPD OK

More Protocols caret

thumbthumb Thumbs Up/Down

Jun 16

From bombs to bromides? Trump’s jousting with biopharma may well boil down to a handshake on drug prices

Jun 9

8 stars: A look back at ASCO spotlights the top cancer drugs to watch, and 1 to forget

Jun 2

Thumbs up: Cancer drug R&D is exploding, get ready for the pricing debate to follow

May 26

Some worthy initiatives out of the FDA fall far short of an effective federal plan to rein in drug prices

More Thumbs Up/Downcaret

DNA Deep dives

Optimizing clinical outcomes for challenging molecules with lipid-based drug delivery

What’s a biotech CEO worth? The top 15 pay packages puts a spotlight on performance — usually

A biotech billionaire tops the list of the 15 highest paid R&D execs in biopharma

The top 15 spenders in the global drug R&D business: 2017

Planning a clinical supply program? Don’t overlook primary packaging.

Alzheimer’s: Learning From a Legacy of Bitter Setbacks

twitter Marco

Hot BioTwitter bot - last updated ago

arrow-thick Most Viral

Autologous CAR-T Cell Manufacturing: Current Standing and Future Directions | GEN

GEN a day

Did someone say pledge? AbbVie may reverse its promise on price hikes

STAT a day

What pledge? AbbVie executives may back off their vow to limit price hikes: report

FiercePharma Eric Sagonowsky a day

FDA targets hundreds of 'rogue' websites illegally selling opioids and other prescription drugs

Washington Post Laurie McGinley a day

Eligo raises $20M to take bacteria-killing CRISPR drug into clinic

FierceBiotech Nick Paul Taylor a day

Q&A: How biotech analysts navigate fickle markets

STAT a day

Gilead nabs Chinese nod for Sovaldi, eyeing world's largest hepatitis C patient base

FiercePharma Angus Liu a day

Pfizer Channels Its Inner Biotech

Bloomberg Gadfly Max Nisen a day

Graham-Cassidy now guts Obamacare even more

Vox a day

Senate Hearing Examines Graham-Cassidy Health Care Bill, Sep 25 2017

C-SPAN.org a day

timer Latest

STAT

Q&A: How biotech analysts navigate fickle markets

FierceBiotech

Eligo raises $20M to take bacteria-killing CRISPR drug into clinic

ENDPOINTS NEWS

ProQR spotlights the most encouraging results from a mixed snapshot of efficacy for cystic fibrosis

STAT

Did someone say pledge? AbbVie may reverse its promise on price hikes

STAT

Governors plan a big strategy session over drug pricing

Bloomberg

Revised GOP Health Bill Rewards Holdout Senators' States

FiercePharma

Gilead nabs Chinese nod for Sovaldi, eyeing world's largest hepatitis C patient base

C-SPAN.org

Senate Hearing Examines Graham-Cassidy Health Care Bill, Sep 25 2017

FDA

Minutes of Institutional Review Board (IRB) Meetings - Guidance for Institutions and IRBs

Bloomberg Gadfly

Pfizer Channels Its Inner Biotech

fire Hot This Week

1

ENDPOINTS NEWS

Visualize: What would these 7 biotech companies look like without immigrants?

2

STAT

Alnylam hits all key endpoints in crucial trial of rare disease drug

3

WSJ

The Murky World of Drug Rebates Gets Airing in Lawsuit

4

ENDPOINTS NEWS

Alnylam achieves breakthrough RNAi success as PhIII patisiran study hits all goals

5

STAT

Here's why Alnylam stock took off like a rocket, stunning investors

6

STAT

The Biotech Devil's Dictionary: Your guide to the inanities of industry jargon

7

Vox

"I've covered the GOP repeal plans since day one. Graham-Cassidy is the most radical."

8

STAT

Pharma giant Pfizer launches a tiny startup to kick-start drug research

9

GEN

Autologous CAR-T Cell Manufacturing: Current Standing and Future Directions | GEN

10

Xconomy

Alnylam Data Puts A Nobel Discovery One Step Closer To Approved Drug | Xconomy

Contact Endpoints News

You can also contact John Carroll, Editor at john@endpointsnews.com

← Go back
Thank you for staying with us. It's great to have you on board!
Aww, shucks. Perhaps you can tell us what we could do to make you interested in subscribing?
← Go back